Related Experiment Video
Updated: Aug 17, 2026

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
Published on: January 19, 2022
Neutrophil dysplasia (acquired pseudo-pelger anomaly) caused by ganciclovir
Anne B Taegtmeyer1, Ozay Halil, Alex D Bell
1Department of Transplant Medicine, Harefield Hospital, Harefield, Middlesex, UK.
Abstract:
Two thoracic organ-transplant recipients with persistent cytomegalovirus infection developed morphologic abnormalities in their circulating neutrophils while receiving either ganciclovir or its prodrug valganciclovir. Neither patient was receiving concomitant treatment with mycophenolate mofetil or azathioprine. In both patients, the morphologic abnormalities preceded the development of neutropenia and bone-marrow hypoplasia. The morphologic changes most likely reflected interference of DNA polymerization within bone marrow progenitor cells. The changes resolved completely after the drug was withdrawn.
Insights
Ganciclovir and valganciclovir can cause neutrophil abnormalities in transplant patients with cytomegalovirus infection. These changes, preceding neutropenia, resolved after drug discontinuation, suggesting DNA polymerization interference.
Area of Science:
- Virology
- Hematology
- Pharmacology
Background:
- Cytomegalovirus (CMV) infection is a significant concern in organ transplant recipients.
- Antiviral therapies like ganciclovir and valganciclovir are crucial for managing CMV.
- Neutropenia is a known potential side effect of these antiviral agents.
Observation:
- Two thoracic organ-transplant recipients with persistent CMV infection were treated with ganciclovir or valganciclovir.
- Morphologic abnormalities were observed in the circulating neutrophils of both patients.
- These changes occurred prior to the development of neutropenia and bone marrow hypoplasia.
Findings:
- The neutrophil morphologic abnormalities likely resulted from interference with DNA polymerization in bone marrow progenitor cells.
- The observed changes were specifically linked to ganciclovir or valganciclovir treatment.
- Concomitant use of mycophenolate mofetil or azathioprine was not a factor in these cases.
Implications:
- Early identification of these neutrophil morphologic changes may serve as a potential biomarker for antiviral drug toxicity.
- Understanding this mechanism can inform clinical monitoring and management of transplant patients on ganciclovir or valganciclovir.
- Complete resolution of abnormalities upon drug withdrawal highlights the reversible nature of this adverse effect.
Related Concept Videos
Cytomegalovirus Disease
Cellular Adaptation IV: Dysplasia and Metaplasia